MarketTwits

🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#BPMX +73% Biopharmx Corp -after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.

#AGN +29% Allergan plc - after AbbVie Inc
#ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.

#RIOT +16% Riot Blockchain, Inc. - after climbing 10% on Monday.

#IGC +11% India Globalization Capital, Inc. -after surging 25% on Monday.

#JAGX +10% Jaguar Health, Inc.-regained compliance with all applicable Nasdaq Stock Market listing standards.

#SCPH +5% scPharmaceuticals Inc.

#ENDP +5% Endo International plc -after dropping 6% on Monday.

#KRYS +5% Krystal Biotech Inc -priced 2.5 million share public offering of common stock at $40 per share.

#LEN +4% Lennar Corporation -after the company announced better-than-expected results for its second quarter.

#ARQL +4% ArQule, Inc. -priced 9.25 million share offering at $9.75 per share.

#FDS +4% FactSet Research Systems Inc. -after reporting upbeat Q3 results.

#CANF +4% Can-Fite BioPharma Ltd. -after declining 6% on Monday.

#BHC +4% Bausch Health Companies Inc -after the company announced the US launch of DUOBRII lotion 0.01%/0.045% for plaque psoriasis in adults.

#GNFT +3% Genfit SA- after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.

#SBGL +3% Sibanye Gold Limited

#GRUB +3% Grubhub Inc. -Citigroup upgraded GrubHub from Neutral to Buy.

#NBRV +2% Nabriva Therapeutics PLC – ADR -after reporting the EMA validated the marketing authorization application for lufamulin.

ВНИЗ

#CNAT -58% Conatus Pharmaceuticals Inc - after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.

#ALDX -23% Aldeyra Therapeutics Inc -after the company announced its SOLACE trial in noninfectious anterior uveitis did not achieve statistical significance in its primary or secondary endpoints.

#KERN -11%Akerna Corp. -after dropping 14.09% on Monday.

#IMUX -11% Immunic, Inc. -after rising 90% on Monday.

#GMDA -10% Gamida Cell Ltd -after the company filed for a common stock offering of 4.04 million shares.

#ABBV -9% AbbVie Inc. -after the company announced it will acquire Allergan for $188.24/share.

#BHF -7% Brighthouse Financial, Inc. -Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.

#MDCO -5% The Medicines Company -after reporting a $150 million common stock offering.

#PVTL -4% Pivotal Software, Inc.

#AMAG -4% AMAG Pharmaceuticals, Inc. -after dropping 4% on Monday.

#BYND -3% Beyond Meat, Inc. - after dropping 8% on Monday.

#SHOP -3% Shopify Inc. -Wedbush downgraded Shopify from Outperform to Neutral.

#NERV -3% Minerva Neurosciences, Inc. -after surging 40% on Monday.

7.2K views12:49